The National Genomic Test Directory for Cancer specifies the genomic tests commissioned by NHS England for cancer, eligibility criteria, and how to order them.
The Cancer Test Directory is sub-divided into five categories:
- Adult Solid Tumours
- Neurological Tumours,
- Sarcomas
- Haematological Cancer
- Paediatric Tumours
Access to genomic services for HaemOnc patients will continue to be through your Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS). An SIHMDS incorporates all pathology specialisms associated with haematological malignancy diagnosis, including:
- morphology
- histology (including immunohistochemistry)
- immunophenotyping
- cytogenetics
- FISH
- molecular studies.
Central and South Genomics covers three SIHMDS groups:
Wessex SIHMDS group
Genomic haemato-oncology diagnostics are funded centrally by NHSE and so referring Trusts will not be charged for these services if they refer testing to their designated local GLH. Please note that non-genetic activity carried out within an SIHMDS is funded separately and will still be charged for.
Whole Genome Sequencing (WGS) is commissioned by NHS England for a sub-group of patients with haematological cancers. More information and test information sheets can be accessed by clicking here.
If a test is not listed on the Test Directory this means it is not currently commissioned by NHS England. The process for requesting additions and updates to the Test Directory is detailed here.